Conformational Features of Beta-Amyloid Peptide 25–35

被引:0
|
作者
Agaeva G.A. [1 ]
Najafova G.Z. [2 ]
机构
[1] Institute for Physical Problems, Baku State University, Baku
[2] French-Azerbaijani University, Baku
关键词
beta-amyloid peptide 25–35; conformation; molecular dynamics method; molecular mechanics method;
D O I
10.1134/S0006350923050020
中图分类号
学科分类号
摘要
Abstract: Beta-amyloid peptide (Aβ) plays an important role in the mechanism of neurodegeneration in Alzheimer’s disease. A fragment of beta-Aβ(25–35) amyloid peptide with the sequence GSNKGAIIGLM is considered to be the functional domain of the amyloid Aβ peptide responsible for its neurotoxic properties and the biologically active Aβ region. Conformational analysis by the method of molecular mechanics of each peptide segment of the C-terminal part of the peptide revealed a limited number of the most probable conformations and clearly defined the forces stabilizing the structures. The results we obtained showed that the Aβ(25–35) peptide energetically preferentially adopts the a-helical conformation at the C-terminal octapeptide segment. The molecular dynamics method was used to model the intramolecular mobility pattern of the Aβ(25–35) peptide molecule. It is shown that in the low-energy conformations of the Aβ(25–35) peptide, the flexible structures in its N-terminal region were oriented differently with respect to the structures in the C-terminal part. © Pleiades Publishing, Inc. 2023. ISSN 0006-3509, Biophysics, 2023, Vol. 68, No. 5, pp. 712–718. Pleiades Publishing, Inc., 2023. Russian Text The Author(s), 2023, published in Biofizika, 2023, Vol. 68, No. 5, pp. 871–877.
引用
收藏
页码:712 / 718
页数:6
相关论文
共 50 条
  • [1] The neurochemical and behavioral effects of beta-amyloid peptide(25-35)
    Chen, SY
    Wright, JW
    Barnes, CD
    BRAIN RESEARCH, 1996, 720 (1-2) : 54 - 60
  • [2] Chemical degradation of beta-amyloid [25-35] peptide under physiological conditions
    Jost, K
    Varga, J
    Szabo, Z
    Penke, B
    Zarandi, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (04) : 141 - 141
  • [3] Effect of beta-Amyloid Peptide Fragment 25-35 on Nonselective Permeability of Mitochondria
    E. F. Shevtzova
    E. G. Kireeva
    S. O. Bachurin
    Bulletin of Experimental Biology and Medicine, 2001, 132 : 1173 - 1176
  • [4] beta-amyloid peptide secretion by a microglial cell line is induced by beta-amyloid-(25-35) and lipopolysaccharide
    Bitting, L
    Naidu, A
    Cordell, B
    Murphy, GM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (27) : 16084 - 16089
  • [5] Behavioural effects of beta-amyloid peptide fragment (25-35) beta-administration in rats
    Stepanichev, MY
    Lazareva, NA
    Onufriev, MV
    Mitrokhina, OS
    Moiseeva, YV
    Gulyaeva, NV
    ZHURNAL VYSSHEI NERVNOI DEYATELNOSTI IMENI I P PAVLOVA, 1997, 47 (03) : 597 - 600
  • [6] ALZHEIMER BETA-AMYLOID PEPTIDE-25-35 - ELECTROSTATIC INTERACTIONS WITH PHOSPHOLIPID-MEMBRANES
    TERZI, E
    HOLZEMANN, G
    SEELIG, J
    BIOCHEMISTRY, 1994, 33 (23) : 7434 - 7441
  • [7] Studies of the effects of fragment (25-35) of beta-amyloid peptide on the behavior of rats in a radial maze
    Stepanichev M.Yu.
    Moiseeva Yu.V.
    Lazareva N.A.
    Gulyaeva N.V.
    Neuroscience and Behavioral Physiology, 2005, 35 (5) : 511 - 518
  • [8] In vitro aggregation facilitates beta-amyloid peptide-(25-35)-induced amnesia in the rat
    Delobette, S
    Privat, A
    Maurice, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 319 (01) : 1 - 4
  • [9] Inhibition of LTP in vivo by beta-amyloid peptide in different conformational states
    Schmid, Adrien W.
    Freir, Darragh B.
    Herron, Caroline E.
    BRAIN RESEARCH, 2008, 1197 : 135 - 142
  • [10] Beta-Amyloid as an antibacterial peptide
    Warwick, Paityn
    Vasefi, Maryam
    FASEB JOURNAL, 2021, 35